2025年全球病理學人工智慧市場報告

近年來，病理學領域人工智慧的市場規模迅速擴張，從2024年的12.2億美元成長到2025年的13.8億美元，複合年成長率達12.9%。這一成長可歸因於疾病盛行率的上升、資金籌措舉措的增加、遠端醫療的普及、政府舉措的加強以及對病理服務需求的不斷成長。

預計未來幾年，病理學領域的人工智慧市場將快速成長，到2029年市場規模將達到22.8億美元，年複合成長率（CAGR）為13.3%。預測期內的成長可歸因於人工智慧在臨床試驗中的應用、醫療基礎設施的擴展、跨學科合作、明確的倫理準則的製定以及基於人工智慧的預測分析的發展。預測期內的關鍵趨勢包括人工智慧驅動的診斷工具的開發、與電子健康記錄的整合、電腦輔助診斷（CAD）、人工智慧主導的生物標記發現以及與基因組數據的整合。

未來五年13.3%的預測成長率較我們先前對該市場的預測略微下降0.2%。這一下降主要歸因於美國與其他國家之間的關稅影響。關稅可能會提高從全球供應商進口的組織病理學掃描儀和深度學習模型的成本，從而減緩人工智慧在病理檢查室中的應用。此外，相互關稅以及不斷升級的貿易緊張局勢和限制措施對全球經濟和貿易造成的負面影響也將使這種影響更加廣泛。

未來，對個人化醫療日益成長的需求預計將推動病理學領域人工智慧市場的擴張。個人化醫療是指根據每位患者的特徵、需求和偏好訂做治療方案和醫療保健服務。這種日益成長的需求源於能夠根據個體的基因譜、生活方式因素和特定疾病特徵量身定做治療方案，從而提高療效並最大限度地減少副作用。病理學領域的人工智慧（AI）透過更準確、更有效率地分析醫療圖像和基因數據，為個人化醫療做出貢獻，從而實現更精準的診斷、識別疾病亞型並製定符合患者獨特生物學特徵的治療方案。例如，美國專業會員組織「個人化醫療聯盟」（Personalized Medicine Coalition）於2023年2月發布的報告顯示，2022年共有12種新的個人化藥物獲得核准，約佔所有新治療方法的34%，較往年顯著成長。因此，對個人化醫療日益成長的需求是推動病理學領域人工智慧市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球病理學人工智慧：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 終端用戶產業分析
• 全球病理學人工智慧市場：成長率分析
• 全球病理學人工智慧市場表現：規模與成長，2019-2024年
• 全球病理學人工智慧市場預測：規模與成長，2024-2029年，2034年預測
• 全球病理學人工智慧：潛在市場規模（TAM）

第6章 市場細分

• 全球病理學人工智慧市場：按組件分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
• 軟體
• 掃描器
• 全球病理學人工智慧市場（基於神經網路）：實際數據及預測（2019-2024年、2024-2029年預測、2034年預測）
• 生成對抗網路
• 卷積類神經網路
• 傳統神經網路
• 循環神經網路
• 其他神經網路
• 全球病理學人工智慧市場：按應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 藥物發現
• 疾病診斷與預後
• 臨床工作流程
• 培訓和教育
• 全球病理學人工智慧市場：依最終用戶分類，實際值和預測值，2019-2024年、2024-2029年預測值、2034年預測值
• 製藥和生物技術公司
• 醫院和參考實驗室
• 學術研究機構
• 全球病理學人工智慧市場：細分軟體（按類型）、實際數據和預測數據，2019-2024年、2024-2029年預測值、2034年預測值
• 影像分析軟體
• 診斷工作流程軟體
• 預測分析軟體
• 全球病理學人工智慧市場：依掃描器類型細分，實際數據及預測數據（2019-2024年、2024-2029年預測、2034年預測）。
• 全玻片成像掃描儀
• 數位病理掃描儀
• 頻譜成像掃描儀

第7章 區域和國家分析

• 全球病理學人工智慧市場：按地區、績效和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 全球病理學人工智慧市場：國家、表現與預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 病理學人工智慧市場：競爭格局
• 病理學人工智慧市場：公司概況
  • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • Hamamatsu Photonics KK Overview, Products and Services, Strategy and Financial Analysis
  • Leica Biosystems Overview, Products and Services, Strategy and Financial Analysis
  • Tempus Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Spectra AB
• Lunit Inc.
• Paige AI Inc.
• Inspirata Inc.
• Indica Labs Inc.
• Flagship Biosciences Inc
• Proscia Inc.
• Aiforia Technologies Oy
• Lumea Inc.
• Optrascan Inc.
• PathAI Inc.
• Visiopharm A/S
• Ibex Medical Analytics Ltd.
• BioSymetrics Inc.
• Deep Bio Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年病理學人工智慧市場：提供新機會的國家
• 2029年病理學人工智慧市場：新興細分市場機會
• 2029年病理學人工智慧市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Artificial intelligence (AI) in pathology refers to the application of machine learning algorithms and deep learning models to assist in the analysis of medical images, pattern recognition, and disease diagnosis. AI aids pathologists by automating tasks such as slide analysis, tumor detection, and grading, thereby enhancing diagnostic accuracy and efficiency. It also enables quicker processing of large datasets, which is essential for personalized medicine.

The primary components of artificial intelligence in pathology include software and scanners. Software consists of a collection of programs and algorithms specifically designed to perform tasks related to pathology, such as analyzing medical images, managing data, and supporting diagnostic and research activities. This technology employs various types of neural networks, including generative adversarial networks, convolutional neural networks, conventional neural networks, recurrent neural networks, and others. AI in pathology is utilized in drug discovery, disease diagnosis and prognosis, clinical workflows, as well as training and education. The users of these technologies encompass pharmaceutical and biotechnology companies, hospitals and reference laboratories, and academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the ensuing trade tensions in spring 2025 are having a significant impact on the information technology sector, especially in hardware manufacturing, data infrastructure, and software deployment. Increased duties on imported semiconductors, circuit boards, and networking equipment have driven up production and operating costs for tech companies, cloud service providers, and data centers. Firms that depend on globally sourced components for laptops, servers, and consumer electronics are grappling with extended lead times and mounting pricing pressures. At the same time, tariffs on specialized software and retaliatory actions by key international markets have disrupted global IT supply chains and dampened foreign demand for U.S.-made technologies. In response, the sector is ramping up investments in domestic chip production, broadening its supplier network, and leveraging AI-powered automation to improve resilience and manage costs more effectively.

The artificial intelligence in pathology market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in pathology market statistics, including artificial intelligence in pathology industry global market size, regional shares, competitors with a artificial intelligence in pathology market share, detailed artificial intelligence in pathology market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in pathology industry. This artificial intelligence in pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence in pathology market size has grown rapidly in recent years. It will grow from $1.22 billion in 2024 to $1.38 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to increasing prevalence of disease, increasing funding initiatives, increasing use of telemedicine, increasing government initiatives, and increasing the demand for pathology services.

The artificial intelligence in pathology market size is expected to see rapid growth in the next few years. It will grow to $2.28 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to the growth of AI in clinical trials, expanding healthcare infrastructure, interdisciplinary collaborations, the development of clear ethical guidelines, and the development of AI-based predictive analytics. Major trends in the forecast period include development of AI-powered diagnostic tools, integration with electronic health records, computer-aided diagnosis (CAD), AI-driven biomarker discovery, and integration with genomic data.

The forecast of 13.3% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs are likely to delay AI integration in pathology labs by raising costs for imported histopathology scanners and deep learning models from global suppliers. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for personalized medicine is projected to drive the expansion of the artificial intelligence in pathology market in the future. Personalized medicine involves tailoring medical treatment and healthcare to the unique characteristics, needs, and preferences of each patient. This rising need is attributed to the ability to customize treatments based on individual genetic profiles, lifestyle factors, and specific disease characteristics, thereby enhancing efficacy and minimizing adverse effects. Artificial intelligence (AI) in pathology contributes to personalized medicine by facilitating more accurate and efficient analyses of medical images and genetic data, allowing for more precise diagnoses, improved identification of disease subtypes, and tailored treatment plans that align with a patient's unique biological profile. For instance, a report from the Personalized Medicine Coalition, a US-based professional membership organization, revealed in February 2023 that 12 new personalized medicines were approved in 2022, accounting for about 34% of all new therapies, marking a significant increase compared to previous years. Therefore, the growing demand for personalized medicine is a key factor driving the growth of the artificial intelligence in pathology market.

Leading companies in the artificial intelligence in pathology market are focusing on creating advanced solutions, such as cutting-edge cancer detection tools, to improve diagnostic accuracy, streamline workflows, and enhance patient outcomes. These advanced cancer detection tools utilize AI, leveraging machine learning algorithms and deep learning models to analyze medical images and pathology slides, thereby increasing the accuracy of tumor detection and classification. For example, in March 2022, Paige.ai, a US-based digital pathology company, launched the Paige Lymph Node Module to assist pathologists in detecting breast cancer metastases in lymph nodes. This tool features over 98% sensitivity in detecting breast cancer metastases of any size, including small micrometastases, and employs a proprietary TissueMap to highlight suspicious areas on lymph node slides, enhancing the efficiency and accuracy of pathologists' reviews while significantly reducing the time needed for analysis.

In March 2023, Clarapath, a US-based medical robotics firm, acquired Crosscope for an undisclosed amount. This acquisition aims to enhance Crosscope's digital pathology platform by integrating advanced workflow tools and AI capabilities with Clarapath's automated tissue sectioning system, ultimately improving efficiency and accuracy in pathology laboratories. Crosscope is a US-based company that develops a digital pathology imaging platform that incorporates artificial intelligence to enhance analysis and diagnostics in the field of pathology.

Major companies operating in the artificial intelligence in pathology market are F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Hamamatsu Photonics K.K., Leica Biosystems, Tempus Labs Inc., Spectra AB, Lunit Inc., Paige AI Inc., Inspirata Inc., Indica Labs Inc., Flagship Biosciences Inc, Proscia Inc., Aiforia Technologies Oy, Lumea Inc., Optrascan Inc., PathAI Inc., Visiopharm A/S, Ibex Medical Analytics Ltd., BioSymetrics Inc., Deep Bio Inc., Konfoong Biotech International Co Ltd., Mindpeak GmbH, Qritive Inc., Vuno Inc.

Asia-Pacific was the largest region in the artificial intelligence in pathology market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in pathology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence in pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence in pathology market consists of revenues earned by entities by providing services such as automated diagnostics, image analysis and interpretation, workflow optimization, and remote and telepathology. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence in pathology market also includes sales of high-resolution scanners, graphics processing units (GPUs), workstations, and storage systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Pathology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in pathology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in pathology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence in pathology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component: Software; Scanners
• 2) By Neural Network: Generative Adversarial Networks; Convolutional Neural Networks; Conventional Neural Network; Recurrent Neural Networks; Other Neural Networks
• 3) By Application: Drug Discovery; Disease Diagnosis And Prognosis; Clinical Workflow; Training And Education
• 4) By End User: Pharmaceutical And Biotechnology Companies; Hospitals And Reference Laboratories; Academic And Research Institutes
• Subsegments:
• 1) By Software: Image Analysis Software; Diagnostic Workflow Software; Predictive Analytics Software
• 2) By Scanners: Whole Slide Imaging Scanners; Digital Pathology Scanners; Multi-Spectral Imaging Scanners
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Koninklijke Philips N.V.; Hamamatsu Photonics K.K.; Leica Biosystems; Tempus Labs Inc.; Spectra AB; Lunit Inc.; Paige AI Inc.; Inspirata Inc.; Indica Labs Inc.; Flagship Biosciences Inc; Proscia Inc.; Aiforia Technologies Oy; Lumea Inc.; Optrascan Inc.; PathAI Inc.; Visiopharm A/S; Ibex Medical Analytics Ltd.; BioSymetrics Inc.; Deep Bio Inc.; Konfoong Biotech International Co Ltd.; Mindpeak GmbH; Qritive Inc.; Vuno Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Pathology Market Characteristics

3. Artificial Intelligence In Pathology Market Trends And Strategies

4. Artificial Intelligence In Pathology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence In Pathology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence In Pathology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence In Pathology Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence In Pathology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence In Pathology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence In Pathology Total Addressable Market (TAM)

6. Artificial Intelligence In Pathology Market Segmentation

• 6.1. Global Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Scanners
• 6.2. Global Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Generative Adversarial Networks
• Convolutional Neural Networks
• Conventional Neural Network
• Recurrent Neural Networks
• Other Neural Networks
• 6.3. Global Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Discovery
• Disease Diagnosis And Prognosis
• Clinical Workflow
• Training And Education
• 6.4. Global Artificial Intelligence In Pathology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Hospitals And Reference Laboratories
• Academic And Research Institutes
• 6.5. Global Artificial Intelligence In Pathology Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Image Analysis Software
• Diagnostic Workflow Software
• Predictive Analytics Software
• 6.6. Global Artificial Intelligence In Pathology Market, Sub-Segmentation Of Scanners, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Whole Slide Imaging Scanners
• Digital Pathology Scanners
• Multi-Spectral Imaging Scanners

7. Artificial Intelligence In Pathology Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence In Pathology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence In Pathology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence In Pathology Market

• 8.1. Asia-Pacific Artificial Intelligence In Pathology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence In Pathology Market

• 9.1. China Artificial Intelligence In Pathology Market Overview
• 9.2. China Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence In Pathology Market

• 10.1. India Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence In Pathology Market

• 11.1. Japan Artificial Intelligence In Pathology Market Overview
• 11.2. Japan Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence In Pathology Market

• 12.1. Australia Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence In Pathology Market

• 13.1. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence In Pathology Market

• 14.1. South Korea Artificial Intelligence In Pathology Market Overview
• 14.2. South Korea Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence In Pathology Market

• 15.1. Western Europe Artificial Intelligence In Pathology Market Overview
• 15.2. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence In Pathology Market

• 16.1. UK Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence In Pathology Market

• 17.1. Germany Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence In Pathology Market

• 18.1. France Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence In Pathology Market

• 19.1. Italy Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence In Pathology Market

• 20.1. Spain Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence In Pathology Market

• 21.1. Eastern Europe Artificial Intelligence In Pathology Market Overview
• 21.2. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence In Pathology Market

• 22.1. Russia Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence In Pathology Market

• 23.1. North America Artificial Intelligence In Pathology Market Overview
• 23.2. North America Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence In Pathology Market

• 24.1. USA Artificial Intelligence In Pathology Market Overview
• 24.2. USA Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence In Pathology Market

• 25.1. Canada Artificial Intelligence In Pathology Market Overview
• 25.2. Canada Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence In Pathology Market

• 26.1. South America Artificial Intelligence In Pathology Market Overview
• 26.2. South America Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence In Pathology Market

• 27.1. Brazil Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence In Pathology Market

• 28.1. Middle East Artificial Intelligence In Pathology Market Overview
• 28.2. Middle East Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence In Pathology Market

• 29.1. Africa Artificial Intelligence In Pathology Market Overview
• 29.2. Africa Artificial Intelligence In Pathology Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence In Pathology Market, Segmentation By Neural Network, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence In Pathology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence In Pathology Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence In Pathology Market Competitive Landscape
• 30.2. Artificial Intelligence In Pathology Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Hamamatsu Photonics K.K. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Leica Biosystems Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Tempus Labs Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence In Pathology Market Other Major And Innovative Companies

• 31.1. Spectra AB
• 31.2. Lunit Inc.
• 31.3. Paige AI Inc.
• 31.4. Inspirata Inc.
• 31.5. Indica Labs Inc.
• 31.6. Flagship Biosciences Inc
• 31.7. Proscia Inc.
• 31.8. Aiforia Technologies Oy
• 31.9. Lumea Inc.
• 31.10. Optrascan Inc.
• 31.11. PathAI Inc.
• 31.12. Visiopharm A/S
• 31.13. Ibex Medical Analytics Ltd.
• 31.14. BioSymetrics Inc.
• 31.15. Deep Bio Inc.

32. Global Artificial Intelligence In Pathology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence In Pathology Market

34. Recent Developments In The Artificial Intelligence In Pathology Market

35. Artificial Intelligence In Pathology Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence In Pathology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence In Pathology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence In Pathology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer